The Trump administration's "Manhattan project" for a COVID-19 vaccine has topped its biggest award given only two weeks ago to Novavax, Inc with its latest grant of $2.1 billion to pharmaceutical giant, GlaxoSmithKline, and partner Sanofi Pasteur to "speed up clinical development and manufacturing" of its recombinant vaccine candidate for the novel
Big Pharma Giants GlaxoSmithKline, Sanofi Receive $2.1 Billion to Develop COVID Vaccine
Operation Warp Speed is handing out cash at record velocity and this time, the two largest vaccine companies in the world are benefiting.
By Raul Diego
